Investing.com - InspireMD (NASDAQ: NSPR) reported first quarter EPS of $-0.210, $0.04 worse than the analyst estimate of $-0.170. Revenue for the quarter came in at $1.51M versus the consensus estimate of $2M.
InspireMD's stock price closed at $2.40. It is down -10.780% in the last 3 months and up 30.430% in the last 12 months.
InspireMD saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See InspireMD's stock price’s past reactions to earnings here.
According to InvestingPro, InspireMD's Financial Health score is "fair performance".
Check out InspireMD's recent earnings performance, and InspireMD's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar